09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Related
Seyfarth Synopsis: The SECURE Act—just signed into law late last week—includes probably the most c...
Read More >
On October 11, 2019, Governor Gavin Newsom signed into law AB 51, which will drastically change the ...
Read More >
As the construction industry adapts to operating in a COVID-19 world, the effects of the pandemic wi...
Read More >
On January 31, 2020, U.S. Citizenship and Immigration Services (USCIS) published the Form 1-9 Federa...
Read More >
As employers in the People’s Republic of China have proceeded or attempted to resume operations sin...
Read More >
In celebration of the 100th episode of Corruption Crime and Compliance, Tom Fox, the Compliance Evan...
Read More >